Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine.
about
Gold nanoparticle-spermidine complex blocks the inward rectifier potassium channel.The inward rectifier current inhibitor PA-6 terminates atrial fibrillation and does not cause ventricular arrhythmias in goat and dog models.Molecular mechanisms of chloroquine inhibition of heterologously expressed Kir6.2/SUR2A channels.Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential.Atrial arrhythmogenicity of KCNJ2 mutations in short QT syndrome: Insights from virtual human atria.KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmiaNovel molecular targets for atrial fibrillation therapy.Rotors and the dynamics of cardiac fibrillation.Ionic channels as targets for drug design: a review on computational methods.Antiviral, antifungal, and antiparasitic activities of fluoroquinolones optimized for treatment of bacterial infections: a puzzling paradox or a logical consequence of their mode of action?Styrax blocks inward and outward current of Kir2.1 channel.Atrial Fibrillation Dynamics and Ionic Block Effects in Six Heterogeneous Human 3D Virtual Atria with Distinct Repolarization Dynamics.Commentary: Atrial Fibrillation Dynamics and Ionic Block Effects in Six Heterogeneous Human 3D Virtual Atria with Distinct Repolarization Dynamics.Inward rectifying potassium currents resolved into components: modeling of complex drug actions.Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.Efficient and specific cardiac IK₁ inhibition by a new pentamidine analogue.Partial IK1 blockade destabilizes spiral wave rotation center without inducing wave breakup and facilitates termination of reentrant arrhythmias in ventricles.
P2860
Q33847024-0AB8E9EB-5CAE-4DB2-9B63-559ABAC984A5Q33911538-AFA47D2B-E0E3-4FF3-95F0-777B4D041A03Q36335572-10A303FA-8E39-400C-9830-5A1D7BE44D92Q36398719-D49C8C2A-BBDD-4D87-8F6A-B67115A445DFQ36400524-F7499EBD-5430-4D6E-9843-B4F41F87F87BQ36692867-EDFEC791-5207-4C41-BD0B-485FE88526C7Q37998312-74C06538-734D-42FB-9B72-6C98BC17DFB3Q38085529-8C6F4A3F-D963-4A1A-A347-F6B9422AE357Q38168995-B1C0C798-715C-428E-B93F-31093CA4644DQ38291146-3F8FFF32-1408-488D-98C3-9C811877BA09Q39474348-E8671ED8-D47F-48B7-B14E-1DE397E2C3EAQ42287521-105900F1-E2C7-45DF-86E9-D313A2BF2143Q47133944-104EE4FF-E228-4CA7-9CAF-7B742787A728Q47673332-172B1C22-0BAA-4500-9C5E-032BE6EC34EEQ48595147-E997F0BA-26A1-430B-8AAA-69895B8695C2Q51034289-C4D4DABE-301B-4209-92E9-861368BE6208Q51246736-A95FDB74-8F5B-4139-A2D4-B1294622C83C
P2860
Structural bases for the different anti-fibrillatory effects of chloroquine and quinidine.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Structural bases for the diffe ...... of chloroquine and quinidine.
@ast
Structural bases for the diffe ...... of chloroquine and quinidine.
@en
Structural bases for the diffe ...... of chloroquine and quinidine.
@nl
type
label
Structural bases for the diffe ...... of chloroquine and quinidine.
@ast
Structural bases for the diffe ...... of chloroquine and quinidine.
@en
Structural bases for the diffe ...... of chloroquine and quinidine.
@nl
prefLabel
Structural bases for the diffe ...... of chloroquine and quinidine.
@ast
Structural bases for the diffe ...... of chloroquine and quinidine.
@en
Structural bases for the diffe ...... of chloroquine and quinidine.
@nl
P2093
P2860
P356
P1476
Structural bases for the diffe ...... of chloroquine and quinidine.
@en
P2093
Daniela Ponce-Balbuena
Jeanne A Stuckey
José A Sánchez-Chapula
Sami F Noujaim
Sandeep V Pandit
Tania Ferrer-Villada
P2860
P304
P356
10.1093/CVR/CVR008
P577
2011-01-13T00:00:00Z